针刺联合活血祛瘀剂治疗偏头痛疗效与安全性的meta分析

doi:10.3760/cma.j.issn.1007-1245.2024.13.008

国际医药卫生导报 ›› 2024, Vol. 30 ›› Issue (13): 2148-2157.DOI: 10.3760/cma.j.issn.1007-1245.2024.13.008

针刺联合活血祛瘀剂治疗偏头痛疗效与安全性的meta分析

张瑞环¹ 郝涛² 陈钧³ 孙小琳⁴

¹榆林市中医医院脑病科，榆林　719000；²榆林市中医医院针灸科，榆林　719000；³陕西省中医医院脑病科，西安　710000；⁴榆林市第五医院康复科，榆林　719000

收稿日期:2023-11-18 出版日期:2024-07-01 发布日期:2024-08-01
通讯作者: 孙小琳，Email：929073314@qq.com
基金资助:
陕西省自然科学基金（2023-JC-YB 656）；陕西省中医药管理局资助项目（SZY-NLTL-2024-011）；陕西省中医药管理局资助项目（2021-ZZ-JC018）；榆林市科协青年人才托举计划项目（20230535）

Meta-analysis of on efficacy and safety of acupuncture combined with Huoxue Quyu prescription in treatment of migraine

Zhang Ruihuan¹, Hao Tao², Chen Jun³, Sun Xiaolin⁴

¹Department of Encephalopathy, Yulin Hospital of Traditional Chinese Medicine, Yulin 719000, China; ²Department of Acupuncture and Moxibustion, Yulin Hospital of Traditional Chinese Medicine, Yulin 719000, China; ³Department of Encephalopathy, Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an 710000, China; ⁴Department of Rehabilitation, Yulin NO.5 Hospital, Yulin 719000, China

Received:2023-11-18 Online:2024-07-01 Published:2024-08-01
Contact: Sun Xiaolin, Email: 929073314@qq.com
Supported by:
Natural Science Foundation of Shaanxi Province (2023-JC-YB 656); Shaanxi Provincial Administration of Chinese Medicine Funded Project (SZY-NLTL-2024-011) Shaanxi Provincial Administration of Chinese Medicine Funded Project (2021-ZZ-JC018); Youth Talent Lifting Program of Yulin Science and Technology Association (20230535)

摘要/Abstract

摘要：

目的　评价针刺联合活血祛瘀剂治疗偏头痛的临床疗效、不良反应及治疗潜在机制。方法　检索中国生物医学文献数据库、中国知网、万方数据库、维普数据库、PubMed、Cochrane Library，收集临床随机对照试验（RCT）；对照组患者采用西药治疗，治疗组采用针刺联合活血祛瘀剂治疗；检索时间为建库至2023年4月10日。选用Review Manager5.4软件进行meta分析；改良的定量系统评价证据分级（GRADE）评价结局指标的证据级别；TSA 0.9.5.1Beta软件对主要结局指标进行试验序贯分析。结果　共纳入20项RCT，2 127例患者。meta分析结果显示：主要结局指标中，治疗组的痊愈率（RR=1.93，95%CI 1.56～2.38，P<0.000 01）、总有效率（RR=1.22，95%CI 1.16～1.29，P<0.000 01）均高于对照组；不良反应与对照组比较差异无统计学意义（RR=0.36，95%CI 0.12～1.12，P=0.08）。次要结局指标中：治疗组的视觉模拟量表（VSA）评分（MD=-1.55，95%CI -2.39～-0.70，P=0.000 3）低于对照组；脑动脉血流速度中，治疗组大脑前动脉（ACA）血流速度与对照组比较差异无统计学意义（MD=-1.51，95%CI -3.18～0.16，P=0.08）；治疗组的大脑中动脉（MCA）血流（MD=-4.12，95%CI -5.76～-2.49，P<0.000 01）、大脑后动脉（PCA）血流（MD=-2.73，95%CI -4.14～-1.32，P<0.000 1）均低于对照组。GRADE证据分级结果示：总有效率、痊愈率、不良反应、VAS评分、脑动脉（ACA、MCA、PCA）血流速度均为低级。试验序贯分析示：主要结局指标中，痊愈率、总有效率的纳入的样本量达到meta分析所需要求；而不良反应尚需要更大的样本量验证。结论　针刺联合活血祛瘀剂治疗偏头痛的临床疗效确切，且在一定程度上能改善脑动脉血流速度。

关键词:

偏头痛, 针刺, 活血祛瘀剂, 西药, meta分析, 试验序贯分析

Abstract:

Objective　To evaluate the clinical efficacy, adverse reactions, and potential mechanism of acupuncture combined with Huoxue Quyu prescription in the treatment of migraine. Methods　The China Biomedical Literature Database, CNKI, Wanfang Digital Journal Database, VIP Database, PubMed, and Cochrane Library were searched to collect clinical randomized controlled trials (RCTs) from their establishment to April 10, 2023. The control group were treated with western medicine, and the treatment group with acupuncture and Huoxue Quyu prescription. The review Manager 5.4 software was used for the meta-analysis. The evidence level of the outcome indicators was evaluated by the grading of recommendations assessment, development, and evaluation (GRADE) rating system. The TSA 0.9.5.1 Beta software was used to conduct a sequential analysis of the main outcome measures. Results　A total of 20 RCTs with 2 127 patients were included. The meta-analysis results showed that: among the main outcome indicators, the recovery rate (RR=1.93, 95%CI 1.56-2.38, P<0.000 01) and the total effective rate (RR=1.22, 95%CI 1.16-1.29, P<0.000 01) in the treatment group were higher than those in the control group; there was no statistical difference in adverse reactions between the two groups (RR=0.36, 95%CI 0.12-1.12, P=0.08). Among the secondary outcome measures, the score of Visual Analogue Scale (VAS) in the treatment group (MD=-1.55, 95%CI -2.39--0.70, P=0.000 3) was lower than that in the control group; there was no statistical difference in the anterior cerebral artery (ACA) blood flow velocity (MD=-1.51, 95%CI -3.18-0.16, P=0.08) between the two groups; the middle cerebral artery (MCA) blood flow (MD=-4.12, 95%CI -5.76--2.49, P<0.000 01) and posterior cerebral artery (PCA) blood flow (MD=-2.73, 95%CI -4.14--1.32, P<0.000 1) in the treatment group were lower than those in the control group. The GRADE evidence grading results showed that total effectiveness, recovery rate, adverse reactions, VAS score, and cerebral artery (ACA, MCA, and PCA) blood flow velocities were all low. The sequential analysis of the trials showed that among the main outcome indicators, the included sample size of recovery rate and total effective rate met the requirements of the meta-analysis. However, the adverse reactions still needed to be verified by a larger sample. Conclusion　Acupuncture combined with Huoxue Quyu prescription has definite clinical effect on migraine, and can improve cerebral artery blood flow velocity to a certain extent.

Key words:

Migraine, Acupuncture, Huoxue Quyu prescription, Western medicine, Meta-analysis, Trail sequential analysis

张瑞环郝涛陈钧孙小琳.

针刺联合活血祛瘀剂治疗偏头痛疗效与安全性的meta分析 [J]. 国际医药卫生导报, 2024, 30(13): 2148-2157.

Zhang Ruihuan, Hao Tao, Chen Jun, Sun Xiaolin.

Meta-analysis of on efficacy and safety of acupuncture combined with Huoxue Quyu prescription in treatment of migraine [J]. International Medicine and Health Guidance News, 2024, 30(13): 2148-2157.

参考文献

[1] Wang X, Yin Z, Lian Y, et al. Premonitory symptoms in migraine from China: a multi-clinic study of 4821 patients[J]. Cephalalgia, 2021,41(9):991-1003. DOI: 10.1177/0333102421997850.
[2] He M, Yu S, Liu R, et al. Familial occurrence of headache disorders: a population-based study in mainland China[J]. Clin Neurol Neurosurg, 2016,149:143-146. DOI: 10.1016/j.clineuro.2016.08.010.
[3] Brennan KC, Pietrobon D. A systems neuroscience approach to migraine[J]. Neuron, 2018,97(5):1004-1021. DOI: 10.1016/j.neuron.2018.01.029.
[4] Dodick DW. Migraine[J]. Lancet, 2018,391(10127):1315-1330. DOI: 10.1016/S0140-6736(18)30478-1.
[5] Pi C, Tang W, Li Z, et al. Cortical pain induced by optogenetic cortical spreading depression: from whole brain activity mapping[J]. Mol Brain, 2022,15(1):99. DOI: 10.1186/s13041-022-00985-w.
[6] Li F, Qiu E, Dong Z, et al. Protection of flunarizine on cerebral mitochondria injury induced by cortical spreading depression under hypoxic conditions[J]. J Headache Pain, 2011,12(1):47-53. DOI: 10.1007/s10194-011-0300-1.
[7] 中国医师协会神经内科医师分会,中国研究型医院学会头痛与感觉障碍专业委员会. 中国偏头痛诊治指南(2022版)[J]. 中国疼痛医学杂志,2022,28(12):881-898. DOI:10.3969/j.issn.1006-9852.2022.12.001.
[8] 张烨雯,刘忠琴,徐华春,等. 运用脏气法时论指导治疗偏头痛患者的临床观察[J]. 国际医药卫生导报,2023,29(20):2906-2910. DOI:10.3760/cma.j.issn.1007-1245.2023. 20.017.
[9] Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition[J]. Cephalalgia, 2018,38(1):1-211. DOI: 10.1177/0333102417738202. DOI:10.1177/0333102417738202.
[10] 郑筱萸.中药新药临床研究指导原则:试行[M].北京:中国医药科技出版社,2022:105-109.
[11] 范中农,林洪,莫婷,等. 复方丹参滴丸配合埋针治疗偏头痛疗效观察[J]. 现代中西医结合杂志,2014,23(30):3382-3384. DOI:10.3969/j.issn.1008-8849.2014.30.033.
[12] 廖璐. 红外热成像在针药结合治疗无先兆性偏头痛临床疗效评估中的应用[D].南昌:江西中医药大学,2023.DOI:10.27180/d.cnki.gjxzc.2022.000384.
[13] 王新燕. 针药并用治疗偏头痛临床观察[J]. 河北中医,2011,33(2):249-250. DOI:10.3969/j.issn.1002-2619.2011. 02.054.
[14] 王育琪,代二庆,任万英,等. 针药结合治疗普通型偏头痛临床观察[J]. 武警医学院学报,2006,15(4):343-345. DOI:10.3969/j.issn.1008-5041.2006.04.020.
[15] 张庆力,任文琪. 刺络针法联合通窍活血汤治疗瘀血型无先兆性偏头痛43例[J]. 光明中医,2021,36(9):1471-1474. DOI:10.3969/j.issn.1003-8914.2021.09.039.
[16] 王献林. 偏正头风散配合针刺治疗偏头痛临床研究[J]. 光明中医,2021,36(7):1135-1136. DOI:10.3969/j.issn.1003- 8914.2021.07.044.
[17] 马晓琪. 探讨针灸联合中药治疗偏头痛的临床效果[J]. 养生保健指南,2020(35):80.
[18] 刘金华. 桃红四物汤加味联合针刺疗法治疗偏头痛70例临床观察[J]. 河北中医,2015,37(6):883-884. DOI:10.3969/j.issn.1002-2619.2015.06.031.
[19] 阮绍萍,袁莉,段永宏. 头痛宁方联合针刺治疗血虚型偏头痛60例临床观察[J]. 河北中医,2012,34(12):1777-1779. DOI:10.3969/j.issn.1002-2619.2012.12.007.
[20] 车思瑶,王爱成,赵永烈,等. 芎芷地龙汤联合局部电针刺激疗法治疗偏头痛[J]. 吉林中医药,2022,42(5):550-553. DOI:10.13463/j.cnki.jlzyy.2022.05.015.
[21] 谢菊英,李启秀,罗红缨. 针刺并活血化瘀中药治疗偏头痛临床体会[J]. 中国中医急症,2009,18(3):445-445. DOI:10.3969/j.issn.1004-745X.2009.03.067.
[22] 康桂峰. 针刺结合通窍活血汤加减治疗偏头痛血瘀型临床观察[J]. 实用中医药杂志,2020,36(12):1531-1532.
[23] 张晓忠,邹伟. 针刺配合自拟止痛汤治疗偏头痛50例[J]. 中国中医急症,2011,20(5):799-799. DOI:10.3969/j.issn.1004-745X.2011.05.073.
[24] 洪东方. 针刺四关穴联合丹珍头痛胶囊治疗瘀血阻络型偏头痛49例[J]. 江西中医药大学学报,2020,32(4):65-67.
[25] 韩彩茹.针灸联合中药治疗偏头痛的临床观察[J].内蒙古中医药,2020,39(11):119-120.DOI:10.16040/j.cnki.cn15-1101.2020.11.073.
[26] 鄢燕.针灸联合中药治疗偏头痛的临床效果及有效率观察[J/CD].临床普外科电子杂志,2020,8(4):1304-1305.
[27] 汪波. 中药内服配合针灸对偏头痛的治疗有效率及颅内各动脉平均血流速度值分析[J]. 中外女性健康研究,2021(9):90-91,112.
[28] 李宁. 中药内服配合针灸治疗偏头痛临床观察[J]. 辽宁中医杂志,2008,35(5):739-740. DOI:10.3969/j.issn. 1000-1719.2008.05.053.
[29] 崔银璐,白旸,温如果. 自拟偏正散联合针刺四神聪及辨证取穴治疗风痰阻络型偏头痛临床观察[J]. 光明中医,2020,35(24):3949-3951. DOI:10.3969/j.issn.1003-8914.2020. 24.040.
[30] 张家炎.自拟头痛汤加减结合针灸治疗偏头痛43例临床观察[J].中医药导报,2013,19(5):75-76.DOI:10.13862/j.cnki.cn43-1446/r.2013.05.015.
[31] 肖许珍. 杨文明运用疏风豁痰、化瘀通络法治疗偏头痛经验[J]. 中医杂志,2021,62(23):2042-2045. DOI:10.13288/j.11-2166/r.2021.23.004.
[32] 谢卫平,倪文璐,倪进军. 基于证候和体质研究偏头痛中医病机和分期治疗思路探索[J]. 辽宁中医杂志,2016,43(9):1855-1857. DOI:10.13192/j.issn.1000-1719.2016.09.019.
[33] 金珏,陈晓. "首风"及其方药对头痛论治的启示[J]. 时珍国医国药,2020,31(12):2983-2984. DOI:10.3969/j.issn. 1008-0805.2020.12.046.
[34] 吴艺帆,傅晨,罗超琴,等. 基于数据挖掘的中药治疗瘀血头痛的处方规律研究[J]. 环球中医药,2023,16(3):460-467. DOI:10.3969/j.issn.1674-1749.2023.03.012.
[35] 高冲,刘璐,胡爱菊,等.活血化瘀中药的药理作用研究进展[J].药物评价研究,2013,36(1):64-68.DOI:10.7501/j.issn.1674-6376.2013.01.016.

针刺联合活血祛瘀剂治疗偏头痛疗效与安全性的meta分析

Meta-analysis of on efficacy and safety of acupuncture combined with Huoxue Quyu prescription in treatment of migraine

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	蒋海丽潘虹矫春晓丛丽娜李海强. BIA指导血液透析对患者RRF影响的meta分析 [J]. 国际医药卫生导报, 2024, 30(8): 1301-1306.
[2]	司文丽张全意. 艾司氯胺酮联合苯磺酸瑞马唑仑对ERCP患者影响的meta分析 [J]. 国际医药卫生导报, 2024, 30(7): 1099-1104.
[3]	李金平肖欢. 认知行为疗法对肺癌患者焦虑、抑郁及生活质量干预效果的meta分析 [J]. 国际医药卫生导报, 2024, 30(6): 890-896.
[4]	马静蔺婷婷董宁霞吕文文. EGFR-TKI单药与传统化疗方案治疗进展期NSCLC安全性的网状meta分析 [J]. 国际医药卫生导报, 2024, 30(6): 897-902.
[5]	郝慧慧李真真丁传华韩秀媛郭锡春. 戈舍瑞林对绝经前乳腺癌患者卵巢功能保护的meta分析 [J]. 国际医药卫生导报, 2024, 30(5): 721-731.
[6]	魏婷妤蒋玮婷李紫梦蒋雅昕陈碧贞. 中药漱口液对气管插管患者呼吸机相关性肺炎影响的meta分析 [J]. 国际医药卫生导报, 2024, 30(4): 590-596.
[7]	张凯思马金栋张启慧陈强谱. 预康复干预对结直肠癌患者术后临床结局影响的meta分析 [J]. 国际医药卫生导报, 2024, 30(3): 367-373.
[8]	付安迪周世勇陈珂珂林忠智石若飞王振豪. 腹腔镜与传统开放型手术治疗腹外疝临床疗效的meta分析 [J]. 国际医药卫生导报, 2024, 30(3): 374-380.
[9]	李真真张成娟郝慧慧丁传华刘文山. 他克莫司治疗重症肌无力患者的疗效和生存质量及安全性的meta分析 [J]. 国际医药卫生导报, 2024, 30(2): 192-199.
[10]	张辰喜赵立芳庞鹏张勇. 布托啡诺与曲马多对剖宫产腰硬联合麻醉产妇术中寒战及安全性的meta分析 [J]. 国际医药卫生导报, 2024, 30(2): 200-204.
[11]	张林涛王瑾陈杰袁捷. 调心安神针刺法联合认知行为疗法对慢性失眠症患者的影响 [J]. 国际医药卫生导报, 2024, 30(13): 2225-2229.
[12]	吴沂旎魏文娟吴雪梅韩治华. 滋肝补肾润目汤联合针刺和玻璃酸钠滴眼液治疗干眼症的效果分析 [J]. 国际医药卫生导报, 2024, 30(10): 1659-1663.
[13]	武琰娇陈丽萍侯怀晶徐紫清张凌云. 益生菌治疗轻度认知障碍和阿尔茨海默病患者的有效性及安全性 [J]. 国际医药卫生导报, 2024, 30(1): 1-7.
[14]	赵怡迪梁好陈木欣魏琳. 身体成分与衰弱发生风险关系的meta分析 [J]. 国际医药卫生导报, 2024, 30(1): 8-14.
[15]	刘万磊毛智勇郭永俊. 基于阴阳调衡理论循经针刺在缺血性脑卒中后痉挛性偏瘫患者中的作用 [J]. 国际医药卫生导报, 2023, 29(8): 1075-1079.